Ethical Issue: Who Gets Experimental Ebola Drug?

August 9, 2014   // 0 Comments

Article courtesy of Lauran Neergaard, AP Medical Writer via The Portland Skanner-NNPA WASHINGTON (AP) — The use of an experimental drug to treat two Americans diagnosed with Ebola is raising ethical questions about who gets first access to unproven new therapies for the deadly disease. But some health experts fear debate over extremely limited doses will distract from tried-and-true measure...

Continue reading

More news